NexPoint Real Estate Finance, Inc.

NREF
About the company

NexPoint Real Estate Finance, Inc. operates as a commercial mortgage real estate investment trust in the United States. It focuses on originating, structuring, and investing in first-lien mortgage loans, preferred equity, mezzanine loans, convertible notes, multifamily properties, and common equity investments, as well as multifamily and single-family rental commercial mortgage-backed securities securitizations, promissory notes, revolving credit facilities, and stock warrants or target assets.

Country: United StatesPrice: $12.27Market Cap: $282.6M

Investment snapshot

35%positive consensus
Scored 1d ago

Positive

6

BUY / PASS

Neutral / negative

5 / 5

NEUTRAL / FAIL

Median fair value

$25.90

+111.1% vs price

Models with upside

6 / 17

Positive margin of safety

Strongest signal

Models split on NREF at $12.27 — fair values range $8.89–$49.29

Key risk

Split decision: 5 FAIL · 5 NEUTRAL · 3 BUY · 3 PASS

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILBUYNot rankedPASSNEUTRALNEUTRALNEUTRALFAILBUYPASSBUYFAILNEUTRALPASSFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of Safety+49.6%N/A+58.5%N/AN/A+45.1%N/A+72.3%+75.1%+52.6%N/A-38.0%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-10

Score computed: 2026-11-14

Where It Passes

  • Valuation models86% pass✓ 6✗ 1▾

    Models split on NREF at $12.27 — fair values range $8.89–$49.29

    Graham fair value$24.34
    ✓Graham+49.6% margin vs $12.27
    Lynch fair value$29.56
    ✓Lynch+58.5% margin vs $12.27
    Dreman fair value$22.35
    ✓Dreman+45.1% margin vs $12.27
    Pabrai fair value$44.35
    ✓Pabrai+72.3% margin vs $12.27
    Akre fair value$49.29
    ✓Akre+75.1% margin vs $12.27
    Marks fair value$25.90
    ✓Marks+52.6% margin vs $12.27
    Templeton fair value$8.89
    ✗Templeton-38.0% margin vs $12.27
  • Valuation69% pass✓ 16✗ 9▾

    9 of 13 pass — Greenblatt, Dreman, Schloss +1 more object

    Price / Book Value per Share1.3x
    ✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Price / FFO per Share4.1x
    ✓Graham<= 15x✓Dreman< 12x✓Ackman<= 25
    Basic earnings-growth PEG (dividends excluded)0.42
    ✓Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=None, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / (CFO / Shares)22.5x
    ✗Dreman< 8x
    Valuation ReasonablenessP/E=4.3x, OE Yield=24.5%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/FFO or FFO YieldP/FFO=4.1x, FFO Yield=44.6%
    ✓PabraiP/FFO < 15 or FFO Yield > 10%
    P/B or P/E vs. Historical AverageP/E=4.3x, P/B=1.3x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value45.1% (IV=$22.35 vs Price=$12.27)
    ✓Marks>= 20% below intrinsic value
    Price / EPS4.3x
    ✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price vs. Trailing Low100% of trailing low ($12.27)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+22.31%; #248/6340 (top 3.9%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+1.2597; #1134/6449 (top 17.6%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS4.3x
    ✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E4.00
    ✓Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share1.33x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-21.40%; #4040/6202 (top 65.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth63% pass✓ 9✗ 4▾

    5 of 8 pass — Graham, Ackman and Sleep object

    EPS Growth (3-yr avg, 10-yr window)-47.4%
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)0.42
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR10.4%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$1.74 (2020) -> $2.85 (2025)
    ✓DremanPositive over recent years
    EPS CAGR10.4% CAGR over 5 years
    ✓Dreman> 5% annualized
    Positive Net Income Frequency6/6 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth
    ✗Ackman>= 5%
    Positive EPS Growth Frequency4/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR10.4% CAGR over 5 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR10.4% over 5 years
    ✓Neff7%-20% annualized
  • Verdicts55% pass✓ 6✗ 5▾

    Split decision: 5 FAIL · 5 NEUTRAL · 3 BUY · 3 PASS

    Overall verdict
    ✗GrahamFAIL (1/7)✗BuffettFAIL (1/9)✓LynchBUY (5/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 4)•DremanNEUTRAL (6/10)•MungerNEUTRAL (3/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (0/6)✓MarksBUY (4/5)✓AckmanPASS (5/9)✓TempletonBUY (7/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✓NeffPASS (4/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)

Where It Falls Short

  • Efficiency0% pass✗ 11▾

    All 8 investors flag NREF's efficiency

    Current Ratio
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)
    ✗Buffett> 10%
    ROIC - WACC
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)
    ✗Greenblatt> 25%
    Current Ratio Change YoY
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5
    Return on Invested Capital
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)
    ✗SleepROIC > 12% in a majority of years
  • Cash Flow17% pass✓ 2✗ 5▾

    5 of 6 flag NREF's cash flow — Buffett, Piotroski, Dreman +2 more

    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    Operating Cash Flow$22.9M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=0.43%, ROA=2.31%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)22.5x
    ✗Dreman< 8x
    Positive Operating Cash Flow frequency6/6 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage33% pass✓ 6✗ 9▾

    8 of 12 flag NREF's debt & leverage — Graham, Buffett, Lynch +5 more

    Debt Levels0.41
    ✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 1.99, IC: N/A
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.41
    ✗Lynch< 0.33
    Cash - Long-term Debt$-740.1M
    ✗LynchPositive preferred
    LT Debt / Total Assets Change14.76% -> 14.49%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.41
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Interest Coverage & Debt/EBITDA
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.41
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.4073; #2266/4210 (top 53.8%)
    ✗AsnessTop 30% of eligible cross-section
  • Profitability38% pass✓ 18✗ 17▾

    10 of 16 flag NREF's profitability — Graham, Buffett, Greenblatt +7 more

    Positive EPS (10 years)6/7 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)-47.4%
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)6/7 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)17.0%
    ✓Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)0.75
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)0.42
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR10.4%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE17.7%
    ✓Lynch> 15%
    EBIT / Enterprise Value
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=None, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets2.31%
    ✓PiotroskiROA > 0
    ROA Change YoY0.66% -> 2.31% (delta: +1.65%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=0.43%, ROA=2.31%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity17.7%
    ✓Dreman> 12%
    Margin of SafetyP/FFO=4.1x
    ✓PabraiP/FFO < 15
    Return on Equity15.9% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value45.1% (IV=$22.35 vs Price=$12.27)
    ✓Marks>= 20% below intrinsic value
    Positive Net Income Frequency6/6 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue
    ✗Ackman>= 15%
    Net Income / Shareholders Equity17.7%
    ✓Ackman>= 15%
    5-Year EPS CAGR10.4% CAGR over 5 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+22.31%; #248/6340 (top 3.9%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+17.71%; #940/5226 (top 18.0%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0077; #673/5884 (top 11.4%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR10.4% over 5 years
    ✓Neff7%-20% annualized
    Positive Diluted-EPS Years6/6 years positive
    ✓Schloss>= 70% positive over 5-10 observed years (app rule)

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Trading
SIC Sector: Holding & Investment Offices
Size: Micro Cap($282.6M)
Revenue: N/A
Net Income: $123.1M+242.4% YoY

Financial Snapshot

Operating Margin--
Return on Equity31.7%
Debt / Equity1.99
Current Ratio--
EPS (Diluted)$2.85+179.4% 1y
Sector-adjusted criteria: REIT

Depreciation distorts REIT earnings and book value, so FFO-based criteria replace P/E and free-cash-flow tests, and P/B tests are omitted.

Shareholder Return

Fiscal 2025

Share retirement not available for this company.

Buybacks
—
Dividends
$35.3M

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY22
−94.4% = −83.0% + −67.1%
FY23
172.7% = 31.8% + 106.9%
FY24
70.0% = 91.9% + −11.4%
FY25
179.4% = 242.4% + −18.4%
Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: net income, operating cash flow, depreciation amortization, dividends paid.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, dividends paid.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, dividends paid.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-03-31
FY 2024
Sources
  • 10-K · 2025-03-27
FY 2023
Sources
  • 10-K · 2024-03-22
FY 2022
Sources
  • 10-K · 2023-03-31
FY 2021
Sources
  • 10-K · 2022-02-28
Market Cap$282.6Mcurrent------$620.5Mest.$271.9Mest.$180.6Mest.$197.7Mest.$224.8Mest.
Revenue------------------
Operating Income------------------
Net Income$63.1M↓45%-$922.0K↓102%$17.3M↓22%$22.6M↓13%$123.1M↑242%$36.0M↑92%$18.7M↑32%$14.2M↓83%$83.5M
EPS (Diluted)--$-0.65↓157%$0.29↓46%$0.42↓40%$2.85↑179%$1.02↑70%$0.60↑173%$0.22↓94%$3.93
Gross Margin—————————
Operating Margin—————————
ROE17.7%↓42%———31.7%↑197%10.7%↑98%5.4%↑70%3.2%↓91%34.0%
Total Debt$145.0M↓80%$145.0M↓80%$146.5M↓82%$106.2M↓87%$771.2M↓4%$799.3M↓37%$1.3B↓6%$1.3B↑6%$1.3B
Shareholders' Equity$356.0M↓5%$356.0M↓5%$379.7M↑9%$388.8M↑13%$388.0M↑15%$336.5M↓3%$347.4M↓23%$448.5M↑83%$245.3M
Current Ratio—————————
Debt / Equity0.41↓79%0.41↓79%0.39↓84%0.27↓89%1.99↓16%2.38↓35%3.66↑22%3.01↓42%5.20
Operating Cash Flow$2.0M↓94%$3.2M↓61%-$6.0M↓282%$9.4M↓41%$22.9M↓22%$29.3M↓7%$31.6M↓52%$65.8M↑33%$49.3M
Free Cash Flow------------------

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Trading

NREF vs Peers — Financial Grading

RevenueN/A
Net Income$123.1MMedian
ROE31.7%Top 25%
D/E1.99Bottom 25%
Op. Margin—
Curr. Ratio—
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
REALTY INCOME CORPO$56.1B$58.82$5.7B$1.1B2.7%0.6316.8%—2/71/93/70/3F-Score 64/10
Ventas, Inc.VTR$47.0B$88.92$5.8B$261.5M2.1%1.043.5%—2/71/92/70/3F-Score 62/10
RAYMOND JAMES FINANCIAL INCRJF$32.4B$168.64$15.9B$2.1B17.1%0.28——3/93/93/71/3F-Score 64/11
ROYAL GOLD INCRGLD$21.7B$256.89$1.0B$466.3M6.5%0.1361.9%3.124/92/94/70/3F-Score 44/11
iShares Ethereum Trust ETFETHA$19.4B$44.02—$2.3B——————————
KIMCO REALTY CORPKIM$17.0B$25.55$2.1B$584.7M5.6%0.7436.0%—3/72/94/70/3F-Score 75/10
LandBridge Co LLCLB$5.6B$73.15$199.1M$30.1M8.9%1.6559.5%4.872/93/92/70/3F-Score 63/11
Digital Turbine, Inc.APPS$927.6M$7.61$565.3M$37.7M-19.6%1.886.0%1.161/92/92/71/3F-Score 70/11